[Effect of the intra-aortic balloon pumping on renal function]

Area of Science:

• Cardiology
• Nephrology
• Critical Care Medicine

Background:

• Cardiac surgery patients often experience renal dysfunction.
• Low cardiac output syndrome (LOS) and acute myocardial infarction (AMI) are associated with significant renal impairment.
• Intra-aortic balloon pump (IABP) is used to support cardiac function in these critical patients.

Observation:

• This study evaluated IABP's effect on renal function in 41 cardiac surgery patients (8 AMI, 4 unstable angina, 29 LOS).
• Renal parameters including creatinine clearance (Ccr), free water clearance (CH2O), urinary N-acetyl-beta-D-glucosaminidase (U-NAG), and fractional excretion of beta 2-microglobulin (FE beta 2M) were monitored.
• Patients were grouped based on renal and cardiac function response to IABP within 6-12 hours.

Findings:

• Group I (25 patients) showed significant improvement in both renal and cardiac function within 6 hours of IABP initiation.
• Group II (4 patients) exhibited delayed renal function improvement (12 hours) despite insufficient cardiac recovery.
• Group III (8 patients) demonstrated no improvement in either renal or cardiac function.
• Successful IABP weaning correlated with Ccr > 50 ml/min/1.48 m², CH2O < -0.55 ml/min/1.48 m², and reduced U-NAG and FE beta 2M levels within 12 hours.

Implications:

• IABP is an effective therapy for managing renal dysfunction in patients with cardiogenic shock, LOS, and AMI.
• Early monitoring of specific renal function markers (Ccr, CH2O, U-NAG, FE beta 2M) can predict IABP success and patient outcomes.
• These findings support the use of IABP as a critical intervention to preserve renal function during cardiac emergencies.